Earnings Feed
Start Free
Home/Filings/4/0001273013-08-000073
4//SEC Filing

PHARMACOPEIA INC 4

Accession 0001273013-08-000073

CIK 0001273013operating
View on SEC.govCompany Profile

Filed

Dec 23, 7:00 PM ET

Accepted

Dec 24, 10:51 AM ET

Size

35.1 KB

Accession

0001273013-08-000073

Insider Transaction Report

Form 4
Period: 2008-12-23
PHARMACOPEIA INCPCOP
POSNER BRIAN M
VP, Finance
Transactions
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−28,524$5,705→ 0 total
    Exercise: $6.20Exp: 2016-05-04→ Common Stock (28,524 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−10,212$2,042→ 0 total
    Exercise: $4.67From: 2008-02-28Exp: 2017-02-28→ Common Stock (10,212 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2008-12-23$0.20/sh−74$15→ 0 total
    Exercise: $19.77From: 2001-07-11Exp: 2010-07-11→ Common Stock (74 underlying)
  • Disposition to Issuer

    Common Stock

    2008-12-23−39,813.77→ 0 total
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−24,182$4,836→ 0 total
    Exercise: $3.84From: 2009-02-25Exp: 2018-02-25→ Common Stock (24,182 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−14,027$2,805→ 0 total
    Exercise: $4.94From: 2000-06-21Exp: 2009-06-21→ Common Stock (14,027 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2008-12-23$0.20/sh−12,760$2,552→ 0 total
    Exercise: $5.30From: 2002-09-24Exp: 2011-09-24→ Common Stock (12,760 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−24,831$4,966→ 0 total
    Exercise: $4.75Exp: 2016-03-01→ Common Stock (24,831 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−10,925$2,185→ 0 total
    Exercise: $19.77From: 2001-07-11Exp: 2010-07-11→ Common Stock (10,925 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2008-12-23$0.20/sh−55,818$11,164→ 0 total
    Exercise: $3.84From: 2009-02-25Exp: 2018-02-25→ Common Stock (55,818 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−7,700$1,540→ 0 total
    Exercise: $4.32From: 2003-10-17Exp: 2012-10-17→ Common Stock (7,700 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2008-12-23$0.20/sh−338$68→ 0 total
    Exercise: $4.75From: 2003-10-17Exp: 2016-03-01→ Common Stock (338 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2008-12-23$0.20/sh−46,478$9,296→ 0 total
    Exercise: $6.20Exp: 2016-05-04→ Common Stock (46,478 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2008-12-23$0.20/sh−24,788$4,958→ 0 total
    Exercise: $4.67From: 2008-02-28Exp: 2017-02-28→ Common Stock (24,788 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2008-12-23$0.20/sh−22,000$4,400→ 0 total
    Exercise: $8.88From: 2005-03-16Exp: 2014-03-16→ Common Stock (22,000 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to merger agreement between Pharmacopeia, Inc. ("Pharmacopeia"), Ligand Pharmaceuticals Incorporated ("Ligand") , Margaux Acquisition Corp., a wholly-owned subsidiary of Ligand, and Latour Acquisition, LLC, a wholly-owned subsidiary of Ligand, in exchange for approximately 23,828.54 shares of Ligand common stock having a market value of $2.58 per share on the effective date of the merger and $12,342.27 in cash, without interest. In addition, the reporting person received one contingent value right ("CVR") for each share of the Pharmacopeia common stock disposed of in the merger by the reporting person. The CVRs provide each holder the right to receive approximately $0.50 per share if Ligand enters into a license, sale, development, marketing or option agreement with respect to certain product candidates (other than any agreement with Bristol-Myers Squibb Company or any of its affiliates) on or prior to December 31, 2011.
  • [F2]This option was canceled in connection with Pharmacopeia's offer to purchase all outstanding options, whether vested or unvested, to purchase shares of Pharmacopeia common stock, par value $0.01 per share, which was consummated on December 23, 2008. The reporting person received a cash payment of $0.20 per share of common stock issuable upon exercise of each such option.

Documents

1 file

Issuer

PHARMACOPEIA INC

CIK 0001273013

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001273013

Filing Metadata

Form type
4
Filed
Dec 23, 7:00 PM ET
Accepted
Dec 24, 10:51 AM ET
Size
35.1 KB
View on SEC.gov